Does VALGANCICLOVIR Cause Transplant rejection? 210 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 210 reports of Transplant rejection have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 2.7% of all adverse event reports for VALGANCICLOVIR.
210
Reports of Transplant rejection with VALGANCICLOVIR
2.7%
of all VALGANCICLOVIR reports
33
Deaths
97
Hospitalizations
How Dangerous Is Transplant rejection From VALGANCICLOVIR?
Of the 210 reports, 33 (15.7%) resulted in death, 97 (46.2%) required hospitalization, and 19 (9.0%) were considered life-threatening.
Is Transplant rejection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 210 reports have been filed with the FAERS database.
What Other Side Effects Does VALGANCICLOVIR Cause?
Off label use (1,882)
Cytomegalovirus infection (1,091)
Drug ineffective (886)
Neutropenia (809)
Leukopenia (574)
Drug resistance (524)
Cytomegalovirus viraemia (447)
Pancytopenia (434)
Cytomegalovirus infection reactivation (374)
Death (359)
What Other Drugs Cause Transplant rejection?
TACROLIMUS (3,526)
MYCOPHENOLATE MOFETIL (2,500)
PREDNISONE (1,111)
CYCLOSPORINE (903)
PREDNISOLONE (860)
METHYLPREDNISOLONE (779)
SIROLIMUS (698)
BASILIXIMAB (554)
MYCOPHENOLIC ACID (445)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (437)
Which VALGANCICLOVIR Alternatives Have Lower Transplant rejection Risk?
VALGANCICLOVIR vs VALIUM
VALGANCICLOVIR vs VALPROATE
VALGANCICLOVIR vs VALPROIC ACID
VALGANCICLOVIR vs VALPROMIDE
VALGANCICLOVIR vs VALSARTAN